- Advertise
- Contact Editorial
- Editorial Submission Guidelines
- Contact MJH Life Sciences
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Pharmaceutical Executive-07-01-2019
Pharmaceutical Executive
Creating an ‘Unbossed’ Environment in the Workplace
July 19, 2019
Features
39
7
How one company’s cultural transformation aims to strengthen and empower its talent base.
Proposed Rebates Rule Raises Tough Questions
July 16, 2019
Columns
39
7
The decision to eradicate pharma rebates and prompt direct discounts for federal beneficiaries could, if passed, upend the market-what are the critical questions for new products?
Drug Formulary Decisions: Fixing a Broken System
July 16, 2019
Columns
39
7
Why the time is right for P&T committees to incorporate real-world data and ‘real-world science’ into their product assessments.
The Feasibility of Patient Insights Before Launch
July 16, 2019
Columns
39
7
Obtaining patient perspectives during open-label extension trials.
Compliance Disruptors
July 15, 2019
Features
39
7
Pharm Exec sits down with a pair of big pharma compliance leaders to discuss the strategic move to principles-based policies and the impact of other emerging forces influencing industry compliance practice.
Asia’s Complex Compliance Landscape
July 14, 2019
Features
39
7
A look at some of the key pharma compliance challenges prevalent in the Asia-Pacific region.
Compliance as Usual Doesn’t Cut it Anymore
July 13, 2019
Features
39
7
How pharma companies can bolster their quality management programs to meet FDA’s evolving compliance requirements.
European Pricing Talks: A lot of Smoke—or is it Fire?
July 11, 2019
Columns
39
7
What to make of the simmering public and political angst
FDA Maps Pathway to More Accessible Biosimilars
July 11, 2019
Columns
39
7
New guidances open the door to interchangeables and less costly insulin.
Top Trends, Takeaways from DIA
July 09, 2019
From the Editor
39
7
Highlighting the biggest observations from this year's DIA Annual Meeting-topics likely to continue to dominate industry headlines for the foreseeable future.
Pharma & Biotech: Financial Pulse-Check, Outlook
July 09, 2019
Features
39
7
A review of market performance and trends in 2018 and first quarter of 2019 for the life sciences industry.
Pricing in DTC: Adjusting to the New World
July 01, 2019
Columns
39
7
Strategies for pharma in delivering the full picture to patients.
Pharmaceutical Executive, July 2019 Issue (PDF)
July 01, 2019
Issue PDF
39
7
Click the title above to open the Pharmaceutical Executive July 2019 issue in an interactive PDF format.
Country Report: Egypt
July 01, 2019
Special Sponsored Section
39
7
In the middle of new reforms, and with its political turmoil well in the past, Egypt is striving to open the door to a brave new era of healthcare provision, where improving public healthcare has been assigned priority status.